References
- Product Information: ALIMTA(R) IV injection lyophilized powder for solution, pemetrexed IV injection lyophilized powder for solution. Eli Lilly and Company (per FDA), Indianapolis, IN, 2012.
- Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, et al. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: First results from the research on adverse drug events and reports project. J Clin Oncol 2003; 21:3859–66.
- Edwards IR, Aronson JK. Adverse drug reactions: Definitions, diagnosis, and management. Lancet 2000:356:1255–9.
- Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, et al. Risk assessment in anaphylaxis: Current and future approaches. J Allergy Clin Immunol 2007;120:S2.